Malignancy Arising in Seminal Vesicles in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model

被引:21
|
作者
Yeh, I-Tien [1 ]
Reddick, Robert L. [1 ]
Kumar, Addanki Pratap [2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA
来源
PROSTATE | 2009年 / 69卷 / 07期
关键词
epithelial-stromal tumor; phyllodes tumor; prostate cancer model; TRAMP; seminal vesicle malignancy; EPITHELIAL-STROMAL TUMOR; CANCER; COMPONENTS; PHYLLODES;
D O I
10.1002/pros.20924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Transgenic adenocarcinoma of mouse prostate (TRAMP) mice, derived by prostate specific expression of SV40 large T antigen using the rat probasin promoter, all develop prostate tumors akin to human prostate cancers. More recently, epithelial-stromal (ES) tumors resembling phyllodes tumors have been described in the seminal vesicles of TRAMP mice. We report malignancy arising in these ES tumors of the seminal vesicles in TRAMP mice. METHODS. H&E stained sections from 28-week-old TRAMP mice autopsies were examined. Immunostains (cytokeratin, vimentin, desmin, and MIB-1) and electron microscopy were performed on selected blocks of the genitourinary system and metastatic tumor nodules. RESULTS. The seminal vesicles frequently develop tumors containing broad papillae, with bland epithelium and a cellular spindled stroma just beneath the epithelium. The stromal cells have high nuclear to cytoplasmic ratio, frequent apoptotic cells and mitoses. In some cases, the stromal cells become large mass lesions that overgrow the prostate. The epithelium can also proliferate and become malignant. The tumors have high proliferation indices by MIB-1. Some metastatic tumors have characteristics similar to the seminal vesicle ES tumor. CONCLUSIONS. Metastatic tumors in TRAMP mice show three patterns: (1) A definite adenocarcinoma pattern metastatic from the prostate; (2) poorly differentiated tumor without epithelial differentiation; (3) carcinosarcomatous pattern. The carcinosarcomatous pattern and some of the poorly differentiated tumors likely arise from seminal vesicle ES tumors. Prostate 69: 755-760, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:755 / 760
页数:6
相关论文
共 50 条
  • [21] The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model
    Kaplan, PJ
    Mohan, S
    Cohen, P
    Foster, BA
    Greenberg, NM
    CANCER RESEARCH, 1999, 59 (09) : 2203 - 2209
  • [22] Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer
    Jeet, Varinder
    Ow, Kim
    Doherty, Eboney
    Curley, Ben
    Russell, Pamela J.
    Khatri, Aparajita
    PROSTATE, 2008, 68 (05): : 548 - 562
  • [23] Genistein regulates sex steroid and growth factor signaling in transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Lamartiniere, CA
    Wang, J
    JOURNAL OF NUTRITION, 2004, 134 (05): : 1240S - 1241S
  • [24] Microvascular invasion of the seminal vesicles in adenocarcinoma of the prostate
    Graham, SD
    Napalkov, P
    Watts, L
    Salomao, D
    Bostwick, DG
    PROSTATE, 1996, 28 (06): : 359 - 363
  • [25] Timing of intervention with selenium and soy on cancer chemoprevention in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice
    Christensen, Merrill J.
    Holdaway, Douglas R.
    Thompson, Ryan J.
    Rovelsky, Suzette A.
    Hoskyns, Wesley
    Hopkins, Tyler J.
    Smith, Jordan A.
    Shaw, Brett
    Park, Ji Su
    Archibald, Lauren M.
    FASEB JOURNAL, 2013, 27
  • [26] Centrosome-centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model
    Schatten, H
    Wiedemeier, AMD
    Taylor, M
    Lubahn, DB
    Greenberg, NM
    Besch-Williford, C
    Rosenfeld, CS
    Day, JK
    Ripple, M
    BIOLOGY OF THE CELL, 2000, 92 (05) : 331 - 340
  • [27] MESENCHYMAL STEM CELL MEDIATED CANCER THERAPY INHIBITS TUMOR GROWTH IN THE TRANSGENIC ADENOCARCINOMA OF THE MOUSE PROSTATE (TRAMP) MODEL
    Buono, Roberta
    Abrate, Alberto
    Esposito, Antonio
    Canu, Tamara
    Del Maschio, Alessandro
    Benigni, Fabio
    Hedlund, Petter
    Montorsi, Francesco
    Cavarretta, Ilaria T. R.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E203 - E203
  • [28] Selenium and Soy Modulate Different Processes in Tumor Progression in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mice
    Spencer, Lauren
    Bahme, Bret
    Worden, Joseph
    Urie, Paul
    Christensen, Merrill
    FASEB JOURNAL, 2015, 29
  • [29] Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model
    Raghow, S
    Hooshdaran, MZ
    Katiyar, S
    Steiner, MS
    CANCER RESEARCH, 2002, 62 (05) : 1370 - 1376
  • [30] Angiogenic and proliferative factors in the prostatic microenvironment: senescence and angiogenesis inhibition x lesions in the transgenic adenocarcinoma of mouse prostate (TRAMP) model
    Montico, F.
    Hetzl, A. C.
    Candido, E. M.
    Kido, L. A.
    Lorencini, R. M.
    Cagnon, V. A.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23